Table 3 Characteristics of patients treated with different gas tamponades

Age (years)

53.96 ± 10.43

59.09 ± 9.39

56.88 ± 9.84

0.327^a

Sex (M/F, eyes)

8/20

0/11

2/14

Axial length (mm)

29.41 ± 2.36

29.30 ± 1.23

28.86 ± 1.36

0.657^a

Follow-up period (months)

15.86 ± 8.20

23.82 ± 12.02

14.63 ± 6.92

0.021^a

Baseline CFT (μm)

520.93 ± 170.79

477.91 ± 198.68

487.00 ± 147.45

0.731^a

Post-op CFT (μm)

126.18 ± 50.23

124.64 ± 47.96

162.25 ± 57.80

0.111^a

Change CFT (μm)

396.11 ± 182.52

353.27 ± 191.86

324.75 ± 179.74

0.511^a

Baseline BCVA (log MAR)

0.82 ± 0.39

0.61 ± 0.25

0.61 ± 0.42

0.142^a

Post-op BCVA (log MAR)

0.54 ± 0.37

0.25 ± 0.24

0.25 ± 0.33

0.010^a

Change BCVA (log MAR)

0.28 ± 0.27

0.37 ± 0.25

0.36 ± 0.39

0.581^a

Foveal detachment

12

5

3

0.252^b